Masha Sergeeva, PhD, Principal

  DMPK expert proficient in drug discovery and development in various therapeutic areas experienced in advancing projects from early discovery to clinical development. Successfully implemented several IND-enabling programs, set up first-in-human doses, and analyzed clinical data.

    Combination of expertise in DMPK, Bioanalysis, Safety Assessment, and Clinical Pharmacology; good knowledge of Medicinal Chemistry.

    Experience in preparing documentation for DMPK sections of IND submissions in the following therapeutic areas: anticancer (2002, 2007), antiviral (2005, 2008), and autoimmune (2010).

Click here for a copy of Dr. Sergeeva's curriculum vitae

Click here for Dr. Sergeeva's LinkedIn profile